Antimycobacterial immune responses in patients with pulmonary sarcoidosis

Clinical Respiratory Journal

Volumn 3, Issue 4, 2009, Pages 229-238

  Hörster, Robert ^a   Kirsten, Detlef ^b   Gaede, Karoline Iris ^a   Jafari, Claudia ^a   Strassburg, Alan ^a   Greinert, Ulf ^a   Kalsdorf, Barbara ^a   Ernst, Martin ^a   Lange, Christoph ^a  

^a RESEARCH CENTER BORSTEL   (Germany)

^b KRANKENHAUS GROSSHANSDORF   (Germany)

Author keywords

Interferon gamma; Mycobacterium tuberculosis; Pathogenesis; Sarcoidosis; T cells

Indexed keywords

CULTURE FILTRATE PROTEIN 10; EARLY SECRETORY ANTIGENIC TARGET 6; GAMMA INTERFERON; MYCOBACTERIUM ANTIGEN; TUBERCULIN;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSPOT ASSAY; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOPHENOTYPING; LUNG LAVAGE; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; NONHUMAN; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SARCOIDOSIS; TUBERCULOSIS;

ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BIOPSY; BRONCHOALVEOLAR LAVAGE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOPHENOTYPING; INTERFERON-GAMMA; LEUKOCYTE COUNT; MYCOBACTERIUM TUBERCULOSIS; PROSPECTIVE STUDIES; SARCOIDOSIS, PULMONARY; STATISTICS, NONPARAMETRIC;

EID: 70349243250     PISSN: 17526981     EISSN: 1752699X     Source Type: Journal    
DOI: 10.1111/j.1752-699X.2009.00136.x     Document Type: Article

References (58)

1. Teirstein A, Lesser M. Worldwide distribution and epidemiology of sarcoidosis. In : James DG, editor. Sarcoidosis and Other Granulomatous Diseases of the Lung. New York, Marcel Dekker, 1983 : 101 134.
2. ATS/ERS/WASOG. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999 160 (2 736 755.
3. Moller DR. Potential etiologic agents in sarcoidosis. Proc Am Thorac Soc. 2007 4 (5 465 468.
4. Buck AA. Epidemiologic investigations of sarcoidosis. IV. Discussion and summary. Am J Hyg. 1961 74 : 189 202.
5. Buck AA. Epidemiologic investigations of sarcoidosis. I. Introduction; material and methods. Am J Hyg. 1961 74 : 137 151.
6. Buck AA, Mc KV. Epidemiologic investigations of sarcoidosis. III. Serum proteins; syphilis; association with tuberculosis: familial aggregation. Am J Hyg. 1961 74 : 174 188.
7. Buck AA, Sartwell PE. Epidemiologic investigations of sarcoidosis. II. Skin sensitivity and environmental factors. Am J Hyg. 1961 74 : 152 173.
8. Martinetti M, Tinelli C, Kolek V, et al. The sarcoidosis map': a joint survey of clinical and immunogenetic findings in two European countries. Am J Respir Crit Care Med. 1995 152 (2 557 564.
9. Schurmann M, Lympany PA, Reichel P, Muller-Myhsok B, Wurm K, Schlaak M, Muller-Quernheim J, du Bois RM, Schwinger E. Familial sarcoidosis is linked to the major histocompatibility complex region. Am J Respir Crit Care Med. 2000 162 (3 Pt 1 861 864.
10. Pabst S, Baumgarten G, Stremmel A, Lennarz M, Knufermann P, Gillissen A, Vetter H, Grohe C. Toll-like receptor (TLR) 4 polymorphisms are associated with a chronic course of sarcoidosis. Clin Exp Immunol. 2006 143 (3 420 426.
11. Valentonyte R, Hampe J, Huse K, et al. Sarcoidosis is associated with a truncating splice site mutation in BTNL2. Nat Genet. 2005 37 (4 357 364.
12. Veltkamp M, Wijnen PA, van Moorsel CH, et al. Linkage between toll-like receptor (TLR) 2 promotor and intron polymorphisms: functional effects and relevance to sarcoidosis. Clin Exp Immunol. 2007 149 (3 453 462.
13. Agostini C, Cabrelle A, Calabrese F, et al. Role for CXCR6 and its ligand CXCL16 in the pathogenesis of T-cell alveolitis in sarcoidosis. Am J Respir Crit Care Med. 2005 172 (10 1290 1298.
14. Facco M, Baesso I, Miorin M, Bortoli M, et al. Expression and role of CCR6/CCL20 chemokine axis in pulmonary sarcoidosis. J Leukoc Biol. 2007 82 (4 946 955.
15. Greene CM, Meachery G, Taggart CC, Rooney CP, Coakley R, O'Neill SJ, McElvaney NG. Role of IL-18 in CD4+ T lymphocyte activation in sarcoidosis. J Immunol. 2000 165 (8 4718 4724.
16. Katchar K, Eklund A, Grunewald J. Expression of Th1 markers by lung accumulated T cells in pulmonary sarcoidosis. J Intern Med. 2003 254 (6 564 571.
17. Moller DR, Forman JD, Liu MC, et al. Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis. J Immunol. 1996 156 (12 4952 4960.
18. Robinson BW, McLemore TL, Crystal RG. Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis. J Clin Invest. 1985 75 (5 1488 1495.
19. du Bois RM, Goh N, McGrath D, Cullinan P. Is there a role for microorganisms in the pathogenesis of sarcoidosis? J Intern Med. 2003 253 (1 4 17.
20. Hance AJ. The role of mycobacteria in the pathogenesis of sarcoidosis. Semin Respir Infect. 1998 13 (3 197 205.
21. Carlisle J, Evans W, Hajizadeh R, Nadaf M, Shepherd B, Ott RD, Ritcher K, Drake W. Multiple mycobacterium antigens induce interferon-gamma production from sarcoidosis peripheral blood mononuclear cells. Clin Exp Immunol. 2007 150 (3 460 468.
22. Drake WP, Dhason MS, Nadaf M, Shepherd BE, Vadivelu S, Hajizadeh R, Newman LS, Kalams SA. Cellular recognition of Mycobacterium tuberculosis ESAT-6 and KatG peptides in systemic sarcoidosis. Infect Immun. 2007 75 (1 527 530.
23. Drake WP, Newman LS. Mycobacterial antigens may be important in sarcoidosis pathogenesis. Curr Opin Pulm Med. 2006 12 (5 359 363.
24. Hajizadeh R, Sato H, Carlisle J, Nadaf MT, Evans W, Shepherd BE, Miller RF, Kalams SA, Drake WP. Mycobacterium tuberculosis antigen 85A induces Th-1 immune responses in systemic sarcoidosis. J Clin Immunol. 2007 27 (4 445 454.
25. Richter E, Greinert U, Kirsten D, et al. Assessment of mycobacterial DNA in cells and tissues of mycobacterial and sarcoid lesions. Am J Respir Crit Care Med. 1996 153 (1 375 380.
26. Richter E, Kataria YP, Zissel G, Homolka J, Schlaak M, Muller-Quernheim J. Analysis of the Kveim-Siltzbach test reagent for bacterial DNA. Am J Respir Crit Care Med. 1999 159 (6 1981 1984.
27. Milman N, Lisby G, Friis S, Kemp L. Prolonged culture for mycobacteria in mediastinal lymph nodes from patients with pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2004 21 (1 25 8.
28. Haussinger K, Ballin A, Becker HD, et al. Recommendations for quality standards in bronchoscopy Pneumologie. 2004 58 (5 344 356.
29. Sokal J. Editorial: measurement of delayed skin-test responses. N Engl J Med. 1975 293 (10 501 502.
30. Song Z, Marzilli L, Greenlee BM, et al. Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis. J Exp Med. 2005 201 (5 755 767.
31. Drake WP, Pei Z, Pride DT, Collins RD, Cover TL, Blaser MJ. Molecular analysis of sarcoidosis tissues for mycobacterium species DNA. Emerg Infect Dis. 2002 8 (11 1334 1341.
32. Saboor SA, Johnson NM, McFadden J. Detection of mycobacterial DNA in sarcoidosis and tuberculosis with polymerase chain reaction. Lancet. 1992 339 (8800 1012 1015.
33. Fidler H, Rook GA, Johnson NM, McFadden JJ. Search for mycobacterial DNA in granulomatous tissues from patients with sarcoidosis using the polymerase chain reaction. Am Rev Respir Dis. 1993 147 (3 777 778.
34. Fidler HM, Rook GA, Johnson NM, McFadden J. Mycobacterium tuberculosis DNA in tissue affected by sarcoidosis. BMJ. 1993 306 (6877 546 549.
35. Allen SS, Evans W, Carlisle J, Hajizadeh R, Nadaf M, Shepherd BE, Pride DT, Johnson JE, Drake WP. Superoxide dismutase A antigens derived from molecular analysis of sarcoidosis granulomas elicit systemic Th-1 immune responses. Respir Res. 2008 9 : 36.
36. Bianco A, Spiteri MA. Peripheral anergy and local immune hyperactivation in sarcoidosis: a paradox or birds of a feather. Clin Exp Immunol. 1997 110 (1 1 3.
37. Miyara M, Amoura Z, Parizot C, et al. The immune paradox of sarcoidosis and regulatory T cells. J Exp Med. 2006 203 (2 359 370.
38. Arcangeli G, Calabro S, Cisno F, Zambotto FM, Drigo R, Ferraresso A. Determination of antibodies to borrelia burgdorferi in sarcoidosis. Sarcoidosis. 1994 11 (1 32 3.
39. Martens H, Zollner B, Zissel G, Burdon D, Schlaak M, Muller-Quernheim J. Anti-borrelia burgdorferi immunoglobulin seroprevalence in pulmonary sarcoidosis: a negative report. Eur Respir J. 1997 10 (6 1356 1358.
40. Mitchell DN, McSwiggan DA, Mikhail JR, Heimer GV, Sutherland I. Antibody to herpes-like virus in sarcoidosis. Am Rev Respir Dis. 1975 111 (6 880 882.
41. Nilsson K, Pahlson C, Lukinius A, Eriksson L, Nilsson L, Lindquist O. Presence of Rickettsia helvetica in granulomatous tissue from patients with sarcoidosis. J Infect Dis. 2002 185 (8 1128 1138.
42. Nishiwaki T, Yoneyama H, Eishi Y, Matsuo N, Tatsumi K, Kimura H, Kuriyama T, Masushima K. Indigenous pulmonary Propionibacterium acnes primes the host in the development of sarcoid-like pulmonary granulomatosis in mice. Am J Pathol. 2004 165 (2 631 639.
43. Puolakkainen M, Campbell LA, Kuo CC, Leinonen M, Gronhagen-Riska C, Saikku P. Serological response to Chlamydia pneumoniae in patients with sarcoidosis. J Infect. 1996 33 (3 199 205.
44. Redondo P, Espana A, Sola J, Rocha E, Quintanilla E. Sarcoid-like granulomas secondary to herpes simplex virus infection. Dermatology. 1992 185 (2 137 139.
45. Müller Quernheim J, Gaede KI, Prasse A, Zissel G. Chronic berylliosis. Pneumologie. 2007 61 : 109 116.
46. Koike Y, Seki S, Ohkawa T, Kaneko T, Kogawa K, Fujitsuka S, Hiraide H, Sekine I. CD57+ T cells augment IFN-gamma production in a one-way mixed lymphocyte reaction and their expansion after stem cell transplantation in paediatric patients. Clin Exp Immunol. 2002 130 (1 162 168.
47. Muller-Quernheim J, Schurmann M, Hofmann S, Gaede KI, Fischer A, Prasse A, Zissel G, Schreiber S. Genetics of sarcoidosis. Clin Chest Med. 2008 29 (3 391 414.
48. Grunewald J, Eklund A, Olerup O. Human leukocyte antigen class I alleles and the disease course in sarcoidosis patients. Am J Respir Crit Care Med. 2004 169 (6 696 702.
49. Idali F, Wiken M, Wahlstrom J, Mellstedt H, Eklund A, Rabbani H, Grunewald J. Reduced Th1 response in the lungs of HLA-DRB1*0301 patients with pulmonary sarcoidosis. Eur Respir J. 2006 27 (3 451 459.
50. Rybicki BA, Iannuzzi MC. Sarcoidosis and human leukocyte antigen class I and II genes: it takes two to tango? Am J Respir Crit Care Med. 2004 169 (6 665 666.
51. Wahlströhm J, Kianoosh K, Wigzell H, Olerup O, Eklund A, Grunewald J. Analysis of intracellular cytokines in CD4 and CD8 lung and blood T cells in sarcoidosis. Am J Respir Crit Care Med. 2001 163 : 115 121.
52. Muller-Quernheim J, Pfeifer S, Mannel D, Strausz J, Ferlinz R. Lung-restricted activation of the alveolar macrophage/monocyte system in pulmonary sarcoidosis. Am Rev Respir Dis. 1992 145 (1 187 192.
53. Zheng L, Teschler H, Guzman J, Hubner K, Striz I, Costabel U. Alveolar macrophage TNF-alpha release and BAL cell phenotypes in sarcoidosis. Am J Respir Crit Care Med. 1995 152 (3 1061 1066.
54. Seitzer U, Swider C, Stuber F, et al. Tumour necrosis factor alpha promoter gene polymorphism in sarcoidosis. Cytokine. 1997 9 (10 787 790.
55. Ho LP, Urban BC, Thickett DR, Davies RJ, McMichael AJ. Deficiency of a subset of T-cells with immunoregulatory properties in sarcoidosis. Lancet. 2005 365 (9464 1062 1072.
56. Mack U, Migliori GB, Sester M, et al. LTBI: latent tuberculosis infection or lasting immune response to Mycobacterium tuberculosis? Eur Respi J. In press.
57. Sauzullo I, Mengoni F, Lichtner M, Rossi R, Massetti AP, Mastroianni CM, Vullo V. QuantiFERON-TB Gold and selected region of difference 1 peptide-based assays for the detection of Mycobacterium tuberculosis infection in a cohort of patients enrolled with suspected tuberculosis. Diagn Microbiol Infect Dis. 2008 62 (4 395 401.
58. Goletti D, Stefania C, Butera O, et al. Accuracy of immunodiagnostic tests for active tuberculosis using single and combined results: a multicenter TBNET-Study. PLoS ONE. 2008 3 (10 e3417.